News
Showing 1 to 5 of 54 results
The Leukemia & Lymphoma Society of Canada and the Canadian MPN Network have been working alongside clinicians, pharmaceutical manufacturers and Health Canada to find a solution for Canadians who are impacted by myeloproliferative neoplasms (MPN).
Advocacy, Partners, Myeloproliferative neoplasms
Christina Sit of The Leukemia & Lymphoma Society of Canada, and a co-chair of Cancer Action Now alliance, speaks with CityNews Toronto reporter about why she and other patient advocacy groups and cancer survivors are at Queen's Park on Nov 18, 2024 to "Line up for change" in cancer care.
Advocacy, Events, Media Mentions, Partners
The Leukemia & Lymphoma Society of Canada, with partners like The Collings Stevens Family Foundation, is informing and empowering people impacted by chronic myeloid leukemia (CML), a once-fatal blood cancer now a manageable disease.
Partners, Leukemia
To further extend their collaboration, raise awareness on blood cancers, and to formalize their commitment to their partnership, the CANO and The Leukemia & Lymphoma Society of Canada (LLSC) have signed a memorandum of understanding (MOU) represented by Pascale Rousseau, LLSC Community Programs Manager, and Lorelei Newton, CANO President for 2023/24.
Events, Partners
Graft vs. Host Disease (GvHD) is a serious side effect that commonly affects people who've undergone an allogeneic stem cell transplant (SCT), meaning they've received stem cells to treat their blood cancer. LLSC presented at the International GvHD Symposium in October 2024 in Vancouver on this significant health challenge, and released a podcast episode about GvHD, and other new resources.
Events, Partners, Treatment and side effects